RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $31,370,000 | +75.4% | 3,497,167 | +5.0% | 0.01% | +50.0% |
| Q2 2016 | $17,886,000 | +21.9% | 3,330,692 | +4.4% | 0.00% | +33.3% |
| Q1 2016 | $14,672,000 | -10.1% | 3,189,673 | +1.6% | 0.00% | -25.0% |
| Q4 2015 | $16,323,000 | -17.3% | 3,139,003 | -3.7% | 0.00% | -20.0% |
| Q3 2015 | $19,726,000 | -60.5% | 3,260,470 | +3.0% | 0.01% | -58.3% |
| Q2 2015 | $49,994,000 | +64.7% | 3,166,200 | +13.4% | 0.01% | +71.4% |
| Q1 2015 | $30,350,000 | +15.0% | 2,792,064 | +11.3% | 0.01% | 0.0% |
| Q4 2014 | $26,402,000 | +21.2% | 2,509,678 | +10.4% | 0.01% | +16.7% |
| Q3 2014 | $21,791,000 | -17.3% | 2,272,265 | -0.5% | 0.01% | -14.3% |
| Q2 2014 | $26,365,000 | +8.7% | 2,282,653 | -5.9% | 0.01% | 0.0% |
| Q1 2014 | $24,262,000 | -20.0% | 2,426,242 | +4.1% | 0.01% | -22.2% |
| Q4 2013 | $30,337,000 | -13.2% | 2,330,022 | -0.6% | 0.01% | -25.0% |
| Q3 2013 | $34,962,000 | +97.3% | 2,343,321 | +23.7% | 0.01% | +71.4% |
| Q2 2013 | $17,717,000 | – | 1,894,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |